BRPI0415893A - methods for treating insomnia in a human patient in need of it, for treating primary insomnia in an adult or elderly human patient in need of it and for improving daytime functioning in a human patient in need, use of gaboxadol, and pharmaceutical composition - Google Patents
methods for treating insomnia in a human patient in need of it, for treating primary insomnia in an adult or elderly human patient in need of it and for improving daytime functioning in a human patient in need, use of gaboxadol, and pharmaceutical compositionInfo
- Publication number
- BRPI0415893A BRPI0415893A BRPI0415893-8A BRPI0415893A BRPI0415893A BR PI0415893 A BRPI0415893 A BR PI0415893A BR PI0415893 A BRPI0415893 A BR PI0415893A BR PI0415893 A BRPI0415893 A BR PI0415893A
- Authority
- BR
- Brazil
- Prior art keywords
- need
- human patient
- insomnia
- treating
- adult
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
Abstract
"MéTODOS PARA TRATAR INSÈNIA EM UM PACIENTE HUMANO EM NECESSIDADE DO MESMO, PARA TRATAR INSÈNIA PRIMáRIA EM UM PACIENTE HUMANO ADULTO OU IDOSO EM NECESSIDADE DO MESMO E PARA MELHORAR O FUNCIONAMENTO NO HORáRIO DIURNO EM UM PACIENTE HUMANO EM NECESSIDADE DO MESMO, USO DE GABOXADOL, E, COMPOSIçãO FARMACêUTICA". A presente invenção refere-se a um método para tratar insónia em um paciente humano em necessidade do mesmo pela administração ao citado paciente de uma quantidade de gaboxadol por dia, a citada quantidade sendo eficaz para o tratamento de insónia."METHODS FOR Treating insomnia in a human patient in need of the same, for treating primary insomnia in an adult patient or in need of the same and for improving functioning in the daily schedule of a human patient in the city of Genoa Moxab. AND PHARMACEUTICAL COMPOSITION ". The present invention relates to a method for treating insomnia in a human patient in need thereof by administering to said patient an amount of gaboxadol per day, said amount being effective for treating insomnia.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200301877 | 2003-12-18 | ||
| PCT/DK2004/000861 WO2005058313A1 (en) | 2003-12-18 | 2004-12-14 | Use of gaboxadol for treating insomnia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0415893A true BRPI0415893A (en) | 2007-01-09 |
Family
ID=34684447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0415893-8A BRPI0415893A (en) | 2003-12-18 | 2004-12-14 | methods for treating insomnia in a human patient in need of it, for treating primary insomnia in an adult or elderly human patient in need of it and for improving daytime functioning in a human patient in need, use of gaboxadol, and pharmaceutical composition |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1720547A1 (en) |
| JP (1) | JP2007515415A (en) |
| KR (1) | KR20060103335A (en) |
| CN (1) | CN1893942A (en) |
| AR (1) | AR047154A1 (en) |
| AU (1) | AU2004298313A1 (en) |
| BR (1) | BRPI0415893A (en) |
| CA (1) | CA2550610A1 (en) |
| EA (1) | EA200600989A1 (en) |
| IL (1) | IL176239A0 (en) |
| IS (1) | IS8390A (en) |
| MX (1) | MXPA06006685A (en) |
| NO (1) | NO20063320L (en) |
| SG (1) | SG133601A1 (en) |
| TW (1) | TW200528098A (en) |
| WO (1) | WO2005058313A1 (en) |
| ZA (1) | ZA200602762B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0402118D0 (en) | 2004-01-30 | 2004-03-03 | Merck Sharp & Dohme | Polymorphic forms of a GABAA agonist |
| US20080262029A1 (en) * | 2005-04-29 | 2008-10-23 | H. Lundbeck A/S | Acid and Base Salt Forms of Gaboxadol |
| KR20200053570A (en) * | 2017-09-12 | 2020-05-18 | 오비드 테라퓨틱스 인크. | Use of gaboxadol in the treatment of narcolepsy |
| CN112930182A (en) | 2018-09-20 | 2021-06-08 | 奥维德医疗公司 | Use of gaboxadol for treating tourette's syndrome, tics and stuttering |
| CN113423399A (en) | 2018-12-17 | 2021-09-21 | 奥维德医疗公司 | Use of gaboxadol for treating non-24hour sleep-wake disorders |
| US11364228B2 (en) | 2019-12-18 | 2022-06-21 | Ovid Therapeutics Inc. | Gaboxadol for therapeutic treatment of 1p36 deletion syndrome |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19525598C2 (en) * | 1995-07-13 | 1997-09-25 | Max Planck Gesellschaft | sleeping pills |
| KR20030097890A (en) * | 2001-05-21 | 2003-12-31 | 하. 룬트벡 아크티에 셀스카브 | Granular preparations of gaboxadol |
-
2004
- 2004-12-07 TW TW093137759A patent/TW200528098A/en unknown
- 2004-12-14 CA CA002550610A patent/CA2550610A1/en not_active Abandoned
- 2004-12-14 CN CNA2004800372437A patent/CN1893942A/en active Pending
- 2004-12-14 AU AU2004298313A patent/AU2004298313A1/en not_active Abandoned
- 2004-12-14 KR KR1020067011921A patent/KR20060103335A/en not_active Application Discontinuation
- 2004-12-14 SG SG200704528-9A patent/SG133601A1/en unknown
- 2004-12-14 JP JP2006544213A patent/JP2007515415A/en not_active Withdrawn
- 2004-12-14 EA EA200600989A patent/EA200600989A1/en unknown
- 2004-12-14 EP EP04803014A patent/EP1720547A1/en not_active Withdrawn
- 2004-12-14 WO PCT/DK2004/000861 patent/WO2005058313A1/en active Application Filing
- 2004-12-14 BR BRPI0415893-8A patent/BRPI0415893A/en not_active IP Right Cessation
- 2004-12-14 ZA ZA200602762A patent/ZA200602762B/en unknown
- 2004-12-14 MX MXPA06006685A patent/MXPA06006685A/en unknown
- 2004-12-17 AR ARP040104752A patent/AR047154A1/en not_active Application Discontinuation
-
2006
- 2006-03-30 IS IS8390A patent/IS8390A/en unknown
- 2006-06-11 IL IL176239A patent/IL176239A0/en unknown
- 2006-07-18 NO NO20063320A patent/NO20063320L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG133601A1 (en) | 2007-07-30 |
| IL176239A0 (en) | 2006-10-05 |
| EA200600989A1 (en) | 2006-10-27 |
| AU2004298313A1 (en) | 2005-06-30 |
| AR047154A1 (en) | 2006-01-11 |
| KR20060103335A (en) | 2006-09-28 |
| IS8390A (en) | 2006-03-30 |
| EP1720547A1 (en) | 2006-11-15 |
| ZA200602762B (en) | 2007-06-27 |
| TW200528098A (en) | 2005-09-01 |
| CN1893942A (en) | 2007-01-10 |
| CA2550610A1 (en) | 2005-06-30 |
| MXPA06006685A (en) | 2006-08-23 |
| JP2007515415A (en) | 2007-06-14 |
| WO2005058313A1 (en) | 2005-06-30 |
| NO20063320L (en) | 2006-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0512220A (en) | method for treating, preventing or ameliorating a disease or disorder; pharmaceutical composition; process for the preparation of a compound; and use of a compound | |
| DE502007002101D1 (en) | Medicinal products containing dobesilate calcium for the treatment and prophylaxis of tendon diseases | |
| BRPI0512213A (en) | method for treating, preventing or ameliorating a disease or disorder; pharmaceutical composition; process for the preparation of a compound; and use of a compound | |
| BRPI0417959A (en) | antibody or functional fragment thereof, pharmaceutical composition, method for treating or prophylaxis of stroke and other neurological disorders / disorders in a human, use of an anti-goat antibody, and methods for inhibiting neurodegeneration and / or promoting recovery function in a human patient, to promote axonal growth, to produce an antifungal antibody and to produce an intravenously administered pharmaceutical composition | |
| BRPI0410503A (en) | use of ivermectin for the manufacture of a topical pharmaceutical composition, topical composition and use of the composition | |
| ATE399553T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING DEXTROMETHORPHAN AND QUINIDENE FOR THE TREATMENT OF NEUROLOGICAL DISEASES | |
| BR9911076A (en) | Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis C | |
| BRPI0509140A (en) | processes for treating hiv infection | |
| BRPI0418029A (en) | cd40 antibody formulation and methods | |
| BR0313282A (en) | Selective cyclooxygenase-2 inhibitor compositions and a carbonic anhydrase inhibitor for the treatment of neoplasia | |
| BRPI0519195A2 (en) | oral care composition, and method for preventing or treating dental caries in a human or animal subject | |
| BRPI0415397A (en) | methods and reagents for the treatment of immunoinflammatory disorders | |
| ATE144420T1 (en) | USE OF RILUZOLE TO TREAT PARKINSON'S AND PARKINSON'S SYNDROMES | |
| BR0213540A (en) | Compounds, method for treating a patient's illness or disorder and a pharmaceutical composition comprising them | |
| ITMI20041550A1 (en) | USE OF PROBIOTIC BACTERIA FOR THE PREPARATION OF TOPICAL COMPOSITIONS FOR THE PROTECTION OF THE EPIDERMIS | |
| BR0309095A (en) | Use of osteoprotegerin for the treatment and / or prevention of fibrotic disease. | |
| BR0213100A (en) | Combinations for the treatment of immunoinflammatory disorders | |
| BRPI0412919A (en) | combination of mglur2 antagonist and ache inhibitor for the treatment of chronic and / or acute neurological disorders | |
| BR0306738A (en) | Process and apparatus for preparing crystalline particles of a substance, population of particles, and, pharmaceutical composition | |
| BR0316723A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| BRPI0411176A (en) | pharmaceutical combination consisting of modafinil and another drug | |
| BR0306306A (en) | Composition containing extract of feverfew and use thereof | |
| BRPI0415781A (en) | Method for treating diabetes in a patient and pharmaceutical kit | |
| BRPI0415893A (en) | methods for treating insomnia in a human patient in need of it, for treating primary insomnia in an adult or elderly human patient in need of it and for improving daytime functioning in a human patient in need, use of gaboxadol, and pharmaceutical composition | |
| BR0314713A (en) | Processes and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |